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Abstract.  Ovotransferrin expression during chick em- 
bryo tibia development has been investigated in vivo 
by immunocytochemistry and in situ hybridization. 
Ovotransferrin was first observed in the 7 day car- 
tilaginous rudiment.  At later stages, the factor was 
localized in the articular zone of the bone epiphysis 
and in the bone diaphysis where it was concentrated in 
hypertrophic cartilage,  in zones of cartilage erosion 
and in the osteoid at the chondro-bone junction.  When 
the localization of the ovotransferrin receptors was in- 
vestigated,  it was observed that chondrocytes at all 
stages of differentiation express a low level of the 
oviduct (tissue) specific receptor.  Interestingly,  high 
levels of the receptor were detectable in the 13-d old 
tibia in the diaphysis collar of stacked-osteoprogenitor 
cells and in the layer of derived osteoblasts. High lev- 
els of oviduct receptor were also observed in the 
primordia of the menisci. 
Metabolic labeling of proteins secreted by cultured 
chondrocytes and osteoblasts and Northern blot analy- 
sis of RNA extracted from the same cells confirmed 
and completed the above information.  Ovotransferrin 
was expressed by in vitro differentiating chondrocytes 
in the early phase of the culture and,  at least when 
culture conditions allowed extracellular matrix assem- 
bly, also by hypertrophic chondrocytes and derived 
osteoblast-like cells. Osteoblasts directly obtained 
from bone chips produced ovotransferrin only at the 
time of culture mineralization.  By Western blot analy- 
sis, oviduct receptor proteins were detected at a very 
low level in extract from differentiating and hyper- 
trophic chondrocytes and at a higher level in extract 
from hypertrophic chondrocytes undergoing differentia- 
tion to osteoblast-like cells and from mineralizing  os- 
teoblasts. 
Based on these results, the existence of autocrine 
and paracrine loops involving ovotransferrin and its 
receptor during chondrogenesis and endochondral 
bone formation is discussed. 
NDOCHONDRAL bone formation during  embryo de- 
velopment is characterized by the formation  of hy- 
pertrophic cartilage followed by its calcification,  ero- 
sion,  invasion  by blood vessels,  and  substitution  by bone 
tissue. It has been generally believed that chondrocytes of the 
hypertrophic  cartilage  are  terminally  differentiated  cells 
whose ultimate fate is death. Nevertheless hypertrophic chon- 
drocytes in organ cultures start expressing  proteins consid- 
ered to be bone specific  markers  (Richman and Diewert, 
1988; Strauss et al., 1990; Thesingh  et al., 1991). We have 
reported that chick growth plate hypertrophic chondrocytes, 
when transferred to anchorage dependent cultures in the pres- 
ence of ascorbic acid, further differentiate to osteoblast-like 
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cells (Descalzi Cancedda et al., 1992; Gentili et al.,  1993). 
This differentiation  process is characterized by resumption 
of proliferative  activity, switch from the synthesis of type II 
and X collagen and other cartilage specific extracellular  ma- 
trix macromolecules to synthesis of type I collagen and bone- 
specific proteins,  alkaline phosphatase expression and even- 
tually  deposition of calcium mineral on the newly formed 
matrix.  This process is enhanced  by retinoic  acid and is 
strictly  dependent upon cell-substratum interactions.  More 
recently  we have  proposed that  differentiation  of hyper- 
trophic  chondrocytes toward an osteoblast-like phenotype 
may occur also in vivo underneath early/prospective peri- 
osteum (Galotto,  M., G. Campanile,  G. Robino, F. Descalzi 
Cancedda, E Bianco, and R. Cance~da~ manuscript submitted 
for publication).  In  the course of these  studies,  we have 
shown that hypertrophic chondrocytes differentiating in vitro 
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82-kD glycoprotein,  subsequently identified as ovotransferrin, 
a member of the transferrin family (Gentili et al.,  1993). 
Transferrins are monomeric, glycosylated, 80 kDa pro- 
teins with the property of reversibly binding iron (de Jong 
et al., 1990). Liver is the major site of transferrin production 
in vertebrates and hepatocyte the main cell involved in its 
synthesis.  Other  cells  synthesizing transferrin are  Sertoli 
cells (Skinner et al., 1989),  oviduct cells (McKnight et al., 
1980)  and,  in  the  brain,  ependymal cells  and oligoden- 
droglial cells (Tsutsumi  et al.,  1989;  Bloch et al.,  1985). 
Transferrins are characterized by a large heterogeneity and 
microheterogeneity due  to  variations  in  the  polypeptide 
chain and linked glycan chains and to differences in iron con- 
tent. It is widely accepted that the major role of transferrin 
is iron transport and delivery to cells and tissues, neverthe- 
less it has also been proposed that transferrin is important 
for growth and differentiation of several cell types. In partic- 
ular, transferrin seems to play a significant role as a mito- 
genic factor (Trowbridge and Omary,  1981), as a  neuro- 
(Aizenman et al.,  1986)  and myotrophic agent (Li et al., 
1982)  and  in  embryonic morphogenesis  (Ekblom  et  al., 
1983;  Partanen et al.,  1984). 
By immunolocalization and in situ hybridization, in the 
present report we have deeply investigated the expression of 
ovotransferrin in the developing chick embryo tibia in vivo. 
The results obtained are corroborated by additional observa- 
tions made by studying the expression of the factor in cul- 
tured chondrocytes and osteoblasts. The expression of ovo- 
transferrin receptors  was also  investigated. Based on our 
results, the occurrence of autocrine and paracrine loops of 
ovotransferrin and its receptor during chondrogenesis and 
endochondral bone formation may be postulated. 
Materials and Methods 
lmmunohistochemistry 
For ovotransferrin and oviduct ovotransferrin receptor immunolocalization, 
deparaffinized sections of limbs of day 7, 9, 10, and 13 chick embryos were 
treated with methanol:H202 (49:1) for 30 rain to inhibit endogenous perox- 
idases, then the sections were treated with I mg/ml of hyaluronidase in PBS 
for 20 rain at 37°C, washed in PBS, and exposed to undiluted normal goat 
serum for 20 rain at room temperature. After thorough washing in PBS, the 
sections were exposed to the specific antiserum for I h at room temperature 
and, after additional washing, incubation was continued with a biotinylated- 
goat  anti-rabbit  IgG  (Jackson Immunoresearch Laboratories Inc.  West 
Grove, PA; diluted 1:200 in PBS, 0.1% BSA) for 30 rain at room temper- 
ature. 
To detect sites of antibody binding, sections were challenged with perox- 
idase-conjugated egg-white avidin (Jackson Immunoresearch Laboratories 
Inc.). Sections were then washed in PBS and 50 mM Na acetate pH 5 and 
the peroxidase activity was visualized during a  15-rain  incubation in the 
dark at room temperature by the enzymatic modification of the 3-amino-9- 
ethylcarbazole  substratum  (1  ml  of  a  0.4%  solution  of  3-amino-9- 
ethylcarbazole in dimethylformamide; 9 ml of  50 mM Na acetate pH 5; 0.01 
1111 of 30%  H202).  Sections were then counterstained with Harris' hema- 
toxylin and mounted with Gel/mount from Biomeda Corp (Foster City, 
CA). Sections were studied and photographed in a Zeiss Axiophot (Ober- 
kochen, Germany). 
Antibodies.  An antiserum directed against chicken ovotransferrin was 
obtained in our laboratory by injecting a rabbit with the protein purified 
from conditioned culture medium as described by Descalzi Cancedda et al. 
(1992).  Before use the antiserum was affinity purified on commercially 
available ovotransferrin (Sigma Chem. Co.) bound to Sepbarose 4B-CNBr 
(Pbarmacia LKB Biotechnology, Uppsula, Sweden). The antiserum against 
the chick oviduct ovotransferrin receptor was kindly provided by Dr. John 
J. Lucas (Poola and Lucas, 1988; Fuerkranz et al., 1991). The author stated 
that the antiserum used for the published experiments was no longer avail- 
able; continuing to inject the same rabbit with antigen, antisera preparations 
detected on Western blots few more bands, in addition to the doublet of,,o96 
kD  characteristic  of  the  oviduct  transferrin  receptor.  We  therefore 
preliminarily tested the antibodies specificity by immunoblot experiments 
with chondrocyte extracts (see Results). Monoclonal antibodies (IgGl, k 
chain) specific for the chick embryo red blood cell receptor were prepared 
in the lab of Dr. Anne B. Mason and kindly provided to us before publi- 
cation. 
Preparation of  the Probe  for In Situ Hybridization 
The template used to synthesize the single stranded RNA complementary 
to ovotransferrin was from ovotransferrin cDNA (Jeltsch and Chambon, 
1982).  Probes, labeled with 35S-UTP to specific activity of l0  s cpm//~g, 
were synthesized using SP6 or T7 polymerase. The 440-bp long probes 
were used after alkaline hydrolysis to reduce the size to "~150 bp and after 
selective ethanol and ammonium acetate precipitation to eliminate the unin- 
corporated label. 
In Situ Hybridization 
Slides were dewaxed and passed sequentially through 10 mg/ml proteinase 
K, 4%  paraformaldehyde for 5  rain,  1/400  (vol/vol) acetic anhydride in 
0.1 M triethanolamine, pH 8.0 for 10 rain followed by addition of  the hybrid- 
ization mixture. Hybridization buffer was 50% deionized formamide, 10% 
dextran sulfate, 0.3 M NaCI, 20 mM Tris-HCl, pH 7.6, 5 mM EDTA, Den- 
hart solution Ix, 0.5 mg/ml of tRNA, and 10 mM DTT containing 1.5  × 
l0  s  cpm/pl of the  appropriate probe.  After hybridization overnight at 
50°C, slides were rinsed for 2 h at 50oc in hybridization buffer, digested 
with 20 ag/ml RNAse A for 30 rain at 37°C and then washed a~,ain, de- 
hydrated, and dried in air.  Slides were then dipped in NTB-2 emulsion 
(diluted 1:1 in water) and exposed for 12 d at 4oc, aRer which time they 
were developed, fixed, and mounted with DPX mountant. 
Cell Culture 
Cultures of chondrocytes were performed as described (Castngnoia et al., 
1986).  Cells derived from 6-d chick embryo tibiae, expanded as adherent 
dedifferentiated cells for 2 wk, were transferred to suspension culture for 
3-4 wk until a  homogeneous population of single isolated hypertrophic 
chondrocytes was visible. To obtain osteoblast-like cells as described (Des- 
calzi  Cancedda  et  al.,  1992),  hypertrophic chondmcytes ware  filtered 
through a nylon filter Nitex 42 pm mesh in order to remove cells still ag- 
gregated, digested with hyaluronidase (1 mg/ml), and plated (2  X  los in 
35-ram dish) in Coon's modified F12 culture medium (Ambesi Impiombato 
et al., 1980) supplemented with 10% FCS. After 3 d the medium was sup- 
plemented with 100 #g/ml ascorbic acid and 10 mM//-glycerophosphate 
(complete medium). Culture was continued without cell passaging. When 
indicated retinoic acid was added to the culture medium at 500 nM final 
concentration. Fresh retinoic acid was added and the culture medium was 
changed every day. 
Cultures of chick embryo osteoblasts were obtained from cells outgrown 
from bone chips according to Manduca et al. (1992). 
Cell Labeling and Protein Analysis 
Cells were labeled with [35S]methionine  as described (Descalzi Cancedda 
et al.,  1988).  Samples of culture media were run for protein analysis on 
SDS-PAGE in reducing and unreducing conditions (Bonatti and Descalzi 
Cancedda, 1982).  Immunoprecipitation of specific proteins was performed 
as in Descalzi Cancedda et al.  (1988). 
Western Blot Analysis 
Cell lysates were prepared by adding 0.1% SDS in PBS to the cells. Sam- 
pies, containing ,,o300 pg of proteins, were applied to a  10%  SDS-POly- 
acrylamide gel. Electrophoresis was performed in reducing conditions. Af- 
ter electrophoresis, the gel was blotted to a BA85 nitrocellulose membrane 
(Schleicher and Schuell GmbH, Dassel, Germany) as described by Towbin 
et al. (1979).  After saturation for 16 h with 2% BSA in TTBS buffer (20 
ram Tris HC1 pH 7.5, 500 mM NaCl, 0.05% Tween 20), the blot was in- 
cubated for 2-16 h at room temperature either with the polyclonal antiserum 
directed against the oviduct transferrin receptor or with the monoclonal 
antibodies directed against red blood cell transferrin receptor. After wash- 
ing, bound antibodies were detected by a biotin conjugated anti-rabbit IgG 
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of  ovotransferrin  in  the  de- 
veloping chick embryo tibia. 
Sections of 7 day (a),  10 day 
(b-f), and 13 day (g-i) tibiae 
were stained with ovotransfer- 
rin antiserum, b and g refer to 
the epiphysis  region, c-f and 
h-i refer to the diaphysis  re- 
gion. d-f and  i are enlarge- 
ment of regions indicated by 
arrows in b and h. Ovotrans- 
ferrin is  present in the  car- 
tilaginous rudiment at day 7 
and  epiphysis  of  early  em- 
bryos; at later stages, it is as- 
sociated  with frank chondro- 
cytes  in  the  hypertrophic 
cartilage  and by cells (possi- 
bly stage m  chondrocytes and 
osteocytes)  within  the  first 
bone  at  the  chondro-bone 
junction.  HC,  hypertrophic 
cho~;  MC, marrow cav- 
ity; BT, bone trabecule. Bars: 
(A) 100/~m; (B-C, G-H) 200 
#m; (D-F, I) 50 ttm. 
(H + L) (Jackson  lmmunoresearch  Laboratories  Inc.) and avidine  coupled- 
horseradish peroxidase (Jackson Immunoresearch  Laboratories Inc.) using 
4-chlor-l-napthoi  (Merck Darmstadt, Germany)  as substrate. Antibody  and 
avidine-peroxidase  solutions were made in TTBS containing  2% BSA. 
RNA Extraction and Northern Analysis 
Total RNA was extracted from cells using the guanidinium  thiocyanate 
method (Cbomczynski  and Sacchi, 1987). For Northern  analysis  ~10 pg of 
total RNA, eleotrophoresed  through 1% agarose  gel in  the presence  of  formal- 
dehyde, was blotted  onto  Hybond-N-membranes.  Hybridization  and  washing 
conditions  were as recommended  by Amersham  Corp. Probes  were BST XI- 
BST XI fragment  of ovotransferrin  cDNA (Jeltsch and Chambon, 1982);  Eco 
RI-Eco [] fragment  of clone CHKCTR3 for red blood cell receptor cDNA 
(Chanetal., 1989;  Gerhardtetal., 1991);andpXCR7  for rRNA(gift  fromDr. 
F. Amaldi,  Universit~  di Tor Vergata, Roma, Italy). 
Results 
lmmunolocalization of Ovotransferrin 
in the De.loping Tibia 
To investigate ovotransferrin expression in vivo, sections of 
tibiae from 7-13-d embryos were  stained with antibodies 
Gentili  e! al. Ovotransferrin Expression in the Developing Tibia  581 Figure 2. Localization of ovotransferrin mRNA in the developing chick embryo tibia. In situ hybridization was performed on sections of 
13 day (A-D) and 10 day (E-F) hindlimb with ovotransferrin antisense (A-C, E) and sense (D and F) riboprobes. In A is shown a detail 
of  a digit cartilage rudiment. Other panels refer to diaphysis (B-D) and epiphysis (E-F) of  the tibia. Bars: (A-B, D-F) 200 #m; (C) 100 #m. 
raised against the purified protein. Ovotransferrin was de- 
tected in the cartilaginous rudiment of day 7 embryos (Fig. 
1 a).  During  development the  ovotransferrin was  readily 
identified at  early stages  of development in  the tibia epi- 
physeal regions (Fig. 1 b), but progressively diminished and 
remained restricted to areas immediately adjacent to articu- 
lar surface (Fig.  1 g).  In the bone diaphysis ovotransferrin 
was  located in hypertrophic cartilage and in osteoid at the 
chondro-osseous junction of both 10 (Fig.  1, c-f) and  13- 
(Fig. 1, h-i) d old embryos. Especially at later stages of de- 
velopment, the ovotransferrin was not uniformly distributed 
in the hypertrophic cartilage and was more concentrated in 
the central part and in areas of cartilage erosion. In the os- 
teoid at the chondro-bone junction, elongated ceils trapped 
within the extracellular matrix presented a frank positivity 
(Fig.  1 e); these positive cells were located in both the carti- 
The Journal of Cell Biology, Volume 124,  1994  582 Figure 3. Protein secreted by in vitro differentiating chondrocytes. 
Aliquots of [ssS]methionine-labeled culture media from dediffer- 
entiated chondrocytes grown as adherent cells (lane 1) and trans- 
ferred to suspension culture for 1 day (lane 2), 2 days (lane 3), 3 
days (lane 4), 4 days (lane 5), 7 days (lane 6), and 2 wk (lane 7) 
were analyzed on 12.5 % polyacrylamide gel. In lane 8 an aliquot 
of labeled culture medium equivalent to the one analyzed in lane 
6 was immunoprecipitated with specific anti-ovotransferrin antise- 
rum.  Culture medium was not supplemented with ascorbic acid. 
Electrophoresis was performed in reducing conditions. OTF refers 
to ovotransferrin. 
lage and the bone side of the first osteoid deposited and were 
tentatively identified as osteoblast-like cells (Stage III chon- 
drocytes) and osteocytes. 
Localization of Ovotransferrin mRNA 
by In Situ Hybridization 
In situ hybridization on paraffin embedded sections of 10- 
and  13-d old hindlimbs was performed to analyze the ovo- 
transferrin mRNA distribution in the forming bones. Similar 
results were obtained when the sections from the 10- and the 
13-d old embryos were analyzed. In Fig. 2 A is shown a de- 
tail of a digit cartilage rudiment from the 13-d old embryo. 
Due to the different timing of limb bone development, this 
image represents an earlier development stage than the one 
of tibia in the same embryo. Other panels refer to diaphysis 
(B-D) and epiphysis (E-F) of the 13- and 10-d old tibia. A 
strong hybridization signal  was displayed by the hypertrophic 
chondrocytes, but not by the more immature chondrocytes 
(A-C). In the epiphyseal region, also the prearticular carti- 
lage presented a strong positive signal (E). As expected no 
signal was  detected when the hybridization was performed 
with the control sense riboprobe (D and F). 
Expression of Ovotransferrin by In Vitro 
Differentiating Chondrocytes: Importance of 
Cell-Extracellular Matrix Interactions 
We have previously shown production of ovotransferrin by 
cultured chondrocytes undergoing differentiation to osteo- 
blast-like cells (Descalzi Cancedda et al.,  1992; Gentili et 
al.,  1993). We therefore focused our attention on the initial 
phase of the in vitro chondrogenesis. Labeled culture media 
were collected from cultures of dedifferentiated chondro- 
cytes grown as adherent cells and transferred and maintained 
for different time in suspension culture. Aliquots of media 
were analyzed on SDS polyacrylamide gel (Fig. 3). Ovotrans- 
ferrin was  identified based on the different electrophoretic 
mobility in reducing and non-reducing conditions (not shown) 
and on its immunoprecipitability by specific antibodies. Ovo- 
transferrin was not produced by dedifferentiated cells, was 
secreted by differentiating chondrocytes during the first week 
of  the in vitro chondrogenesis, but it was absent in conditioned 
media from hypertrophic chondrocytes after 2 wk suspension 
culture. 
This last observation was  in apparent contrast with the 
presence of ovotransferrin in the hypertrophic cartilage zone 
of  embryo tibiae (Fig. I). Therefore  we reasoned that the lack 
of ovotransferrin production by cultured hypertrophic chon- 
drocytes might be due to the absence of a properly organized 
extracellular matrix (obviously present in vivo) in our stan- 
dard culture conditions due to the absence of ascorbic acid 
in the medium. In fact, only in the presence of ascorbic acid 
the collagen chains are correctly hydroxylated and the ex- 
tracellular matrix fully assembled. To test this hypothesis we 
performed one experiment in which a population of dedif- 
ferentiated chondrocytes, split at the time it was transferred 
to suspension culture, was maintained either in the presence 
or it the absence ofascorbic acid. Culture media from 9- and 
13-d culture were analyzed (Fig. 4 A). Only when the culture 
medium was supplemented with ascorbic acid, ovotransfer- 
rin was secreted by the cells. 
In another series of experiments, hypertrophic chondro- 
cytes were obtained after 3 wk suspension culture in the ab- 
sence of ascorbic acid. At that time the chondrocyte popula- 
tion was divided and the suspension culture was continued 
for 5 and 20 additional days either in the presence or in the 
absence of ascorbic acid (Fig. 4  B).  Also in this case the 
presence of ascorbic acid in the culture medium was an abso- 
lute requirement for the production of ovotransferrin. 
Northern blot analysis of  mRNAs extracted from chondro- 
cytes  confirmed the  activation of the  ovotransferrin gene 
transcription in the initial phase of the chondrogenesis (Fig. 
5 A). After 12 d the signal, although at low level, was present 
only in chondrocytes cultured in the presence of ascorbic 
acid (Fig. 5 B), in agreement with the observed presence of 
the protein after 13 d (Fig. 4 A). Ovotransferrin mRNA was 
induced by retinoic acid in the presence of ascorbic acid in hy- 
pertrophic chondrocytes replated as adherent cells (Fig. 5 C). 
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assembly  and  ovotransferrin 
production by cultured chon- 
drocytes.  Aliquots  of  [~S]- 
methionine-labeled  culture me- 
dia were analyzed on  12.5% 
polyacrylamide  gel. (.4) Dedif- 
ferentiated chondrocytes trans- 
ferred  to  suspension  culture 
and maintained in culture me- 
dium non supplemented (lanes 
1-2)  or  supplemented (lanes 
3-4) with ascorbic acid for 9 
(lanes I  and 3) or 13 d (lanes 
2  and  4).  (B)  Hypertrophic 
chondrocytes  grown in suspen- 
sion culture for 3 wk in me- 
dium non supplemented with 
ascorbic acid (lane 1), filtered, 
and maintained for 5 additional 
days (lanes 2 and 4) and 20 d 
(lanes 3 andS) in medium non- 
supplemented  with  ascorbic 
acid (lanes 2-3) and supple- 
mented (lanes 4-5) with ascor- 
bic acid. Electrophoresis was 
performed  in  non-reducing 
conditions. OTF refers to ovo- 
transferrin. 
Figure  5.  Northern  blot  of 
RNAs extracted from cultured 
chondrocytes. (A) Dedifferen- 
tiated chondrocytes grown as 
adherent cells (lane 1)  were 
transferred to suspension cul- 
ture for 36 h (lane 2), 3 d (lane 
3),  11  d  (lane 4),  and 3 wk 
(lane 5) without ascorbic acid. 
(B) Dedifferentiated chondro- 
cytes were transferred to sus- 
pension  culture  for  3  days 
(lanes 1  and 3)  and  12  days 
(lanes 2  and 4);  culture me- 
dium was  either  not  supple- 
merited (lanes 1-2) or supple- 
merited  (lanes  3-4)  with 
ascorbic  acid.  (C)  Hyper- 
trophic  chondrocytes  grown 
in suspension for 4  wk (lane 
1), replated as adherent cells 
and grown  in the presence of 
ascorbic acid and retinoic acid 
for  additional  3  (lane  2),  7 
(lane 3), and 15 d (lane 4). At 
the bottom the 28 S rRNA region of the same filter after rehybridization with the probe for rRNA is shown. Probes were as follows: BST 
XI-BST XI fragment of ovotransferrin cDNA, pXCR7  for rRNA. Number on the left refers to RNA size in kb. 
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transferrin by mineralizing os- 
teoblasts.  Osteoblasts grown 
out from bone chips were cul- 
tured for 15 (lane 1) and 39 d 
(lane 2) in the presence of as- 
corbic  acid.  Frank  areas  of 
mineralization  were detect- 
able in the culture after 39 d, 
but not after 15 d. Aliquots of 
[35S]methionine-labeled  cul- 
ture media were analyzed on 
12.5 % polyacrylamide gel. In 
lane 3, an aliquot of labeled 
culture medium equivalent to 
the one analyzed in lane 2 was 
immunoprecipitated  with spe- 
cific anti-ovotransferrin anti- 
serum.  Electrophoresis  was 
performed  in  non-reducing 
conditions. OTF refers to ovo- 
transferrin. 
Expression of  Ovotransferrin by In Vitro 
Mineralizing Osteoblasts 
Osteoblasts grown out from bone chips were maintained in 
culture at confluence for 15 d and 39 d. At variance with the 
15-d culture, after 39 d the culture was heavily mineralized, 
as revealed by microscopic observations and von Kossa stain- 
ing  (not  shown).  Immunoprecipitable  ovotransferrin  was 
produced by the mineralizing osteoblasts, but not by the os- 
teoblasts at an earlier stage of culture (Fig. 6). In other cul- 
tures that underwent mineralization after a different number 
of days, ovotransferrin production was observed only at the 
time of the culture mineralization. 
Expression of Ovotransferrin Receptors in Cultured 
Chondrocytes and Osteoblasts 
Two  different receptors  for  ovotransferrin have  been  de- 
scribed  in  chicken  cells:  one  specific  for  chick embryo 
erythroid cells (Schmidt et al.,  1985,  1986) and one iden- 
tiffed in the hen oviduct (Poola and Lucas, 1988; Fuerkranz 
et al.,  1991). Recombinant clones of the chicken red blood 
cell ovotransferrin receptor gene and cDNA have been iso- 
lated and sequenced (Chan et al.,  1989;  Gerhardt et ai., 
1991) and the developmental pattern of expression of the red 
blood cell receptor has been investigated by Northern blot 
in  various  chick embryonic tissues  (Chan  and  Gerhardt, 
1992). The receptor mRNA is present at significantly  higher 
levels (from 20 times to 200 or more times) in erythroid cells 
than in nonerythroid cells and decline during embryonic de- 
velopment in all tissues, reaching undetectable levels in all 
of the nonerythroid tissues by hatching. Monoclonal anti- 
bodies specific for the chick embryo red blood cell receptor 
are available.  For the oviduct transferrin receptor,  a poly- 
clonal antiserum directed against this receptor has been de- 
scribed (Poola and Lucas,  1988).  The antiserum strongly 
stained adult oviduct, ovary and liver, but not red blood cells 
either from embryos or from adult chicken (Fuerkranz et al., 
1991). 
When the  RNAs  extracted  from cultured chondrocytes 
were analyzed by Northern blot using the erythroid ovotrans- 
ferrin receptor cDNA (not shown), the probe showed high 
level  of ovotransferrin mRNA in the RNA extracted from 
embryonic liver and identified a barely detectable mRNA of 
the correct size in the RNAs from chondrocytes but not from 
dedifferentiated and  osteoblast-like  cells.  Similar  results 
were obtained by RNase protection experiments  (Castag- 
nola, P., unpublished observations). 
To investigate the presence of receptor proteins and, at the 
same time, to test antibody specificities, we preliminarily 
performed  immunoblot experiments  on  cell  lysates  from 
chondrocytes and  osteoblasts  cultured  in  different condi- 
tions. At the protein concentration loaded on the gel (300 
#g),  the  monoclonal  antibodies  directed  against  the  red 
blood cell receptor recognized the characteristic 95-kD pro- 
tein in an embryonic liver extract, but failed to identify any 
protein in all samples from cultured cells (not shown). Posi- 
tive results were obtained with the antiserum recognizing the 
oviduct receptor (Fig. 7). The antibodies recognized in ad- 
herent dedifferentiated cells and in chondrocytes cultured in 
suspension a doublet of 95 kD comigrating with the bands 
detected in hen oviduct microsomes (Fig. 7 A). The number 
of receptor molecules in the cell lysates highly increased 
during the differentiation of hypertrophic chondrocytes to 
osteoblast-like cells promoted by retinoic acid (Fig. 7 B). 
Comparable amount of receptor was present in lysates from 
mineralizing osteoblasts (Fig. 7 C). The anti-oviduct recep- 
tor serum, in addition to the characteristic 95-kD doublet, 
recognized  few  more  minor  bands  of higher  molecular 
weight. 
Expression of  Ovotransferrin Receptors 
in the Developing Tibia 
Sections of  tibiae from 7-, 9-, and 13-d embryos were stained 
with the antiserum raised against the oviduct ovotransferrin 
receptor and monoclonal antibodies against the red blood 
cell receptor. With the antiserum against the oviduct recep- 
tor, a low positivity was observed in the cartilaginous rudi- 
ment at day 7 (Fig. 8 a) and in both the epiphysis and the 
diaphysis of the 9-d bone (Fig.  8, b-c). In the 13-d bone, 
epiphyseal cells express only low levels of receptor (Fig. 8 
d); a very strong staining was instead observed in the diaphy- 
sis at the chondro-bone junction (Fig.  8, e-f). At a higher 
magnification it is evident that the highly positive cells are 
located in the collar of stacked-osteoprogenitor-cells and in 
the layer of derived osteoblasts (Fig.  8 f). It is interesting 
to note that at  13  day also  the primordia of the menisci 
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of  transferrin  receptor.  Ali- 
quots of cell lysates contain- 
ing 300/~g proteins were run 
on  SDS-polyaerylamide gel, 
blotted to nitrocellulose filter 
and subjected to immunoblot 
with antiserum  directed against 
oviduct ovotransferrin recep- 
tor. (A) Deditferentiated  chon- 
drocytes  grown  as  adherent 
ceils (lane 2) and transferred 
to suspension culture for 15 d 
(lane 3). In lane 1 an aliquot 
of hen oviduct microsomes (a 
gift of Dr. J. J. Lucas) is run 
for comparison.  (B)  Hyper- 
trophic chondrocytes replated 
as adherent cells and treated 
with 500 nM retinoic acid for 
3 (lane I ), 6 (lane 2), 10 (lane 
3), 13 (lane 4), and 27 (lane 
5)  d.  Mineral  deposits were 
observed in the  cell layer at 
the last time of  the culture. (C) 
Osteoblasts maintained in cul- 
ture  for 39  d,  a  time  when 
mineralization  has  already 
occurred. 
is  stained  by  the  anti-ovotransferrin  receptor  antibodies 
(Fig.  8 d). 
In the 13-d embryo, when the antibodies directed against 
the red blood cell receptor were used, only a faint peroxidase 
activity was  observed in  the  epiphysis  and  in  the hyper- 
trophic cartilage zone. Enrichment of  this receptor was never 
observed in osteoprogenitor cells and derived osteoblasts, as 
in the case of the oviduct receptor (not shown). 
Discussion 
In this study we have investigated the ovotransferrin expres- 
sion during development of the chick embryo tibia.  Ovo- 
transferrin  is  present  in  the  first  cartilaginous  rudiment. 
While development continues, in the epiphyseal region, ovo- 
transferrin decreases and remains restricted to the articular 
zone. In the diaphysis the factor, which is abundant in the 
hypertrophic cartilage, progressively concentrates in zones 
of cartilage erosion and in the osteoid at the chondro-bone 
junction. The studies with cultured chondrocytes and osteo- 
blasts corroborated the morphological observations. In cul- 
ture, ovotransferrin was expressed by the in vitro differentiat- 
ing chondrocytes in the initial phase of the culture and by 
hypertrophic chondrocytes in the presence of ascorbic acid. 
Ovotransferrin is also expressed by hypertrophic chondro- 
cytes undergoing differentiation to osteoblast-like cells and 
by mineralizing osteoblasts. The two last processes occur in 
the presence of ascorbic acid. 
Two types of transferrin receptors have been described in 
chick cells. One is expressed in cells of the erythroid lineage 
(Schmidt  et al.,  1985,  1986),  the  other is  known  as  the 
oviduct receptor, since was first identified in oviduct ceils 
(Poola and Lucas, 1988), but could be better defined as the 
tissue type transferrin receptor since it is expressed in sev- 
eral tissues (Fuerkranz et al., 1991; our work in this manu- 
script).  When the presence of the ovotransferrin receptors 
was investigated in the developing tibia,  it was found that, 
at all developmental stages,  the oviduct receptor, was ex- 
pressed at a  low level and almost evenly distributed in all 
cartilages. High level of oviduct receptor expression was ob- 
served only in the  13  day tibia,  in the collar of stacked- 
osteoprogenitor-cells, and in the layer of  derived osteoblasts. 
The  Western  blot  analysis  on the  extracts  from cultured 
chondrocytes and osteoblasts were in agreement with the im- 
munolocalization experiments. Low levels of oviduct recep- 
tor were detectable in almost all samples but high levels of 
receptor expression were reached only in extracts from hy- 
pertrophic  chondrocytes  differentiating  to  osteoblast-like 
cells and from mineralizing osteoblasts. 
Since hypertrophic and differentiating chondrocytes coex- 
press the ovotransferrin factor and its receptor, the existence 
of autocrine loops playing a role in the control of chondro- 
genesis and hypertrophy could be postulated. At late stage 
of bone development high expression of the receptor is ob- 
served in the osteogenic collar surrounding the hypertrophic 
cartilage. Since the cells in the osteogenic collar do not ex- 
press the ovotransferrin, a paracrine loop leading to the first 
bone deposition, as part of the interplay between chondro- 
cytes and osteogenlc cells, should be considered. In princi- 
ple  chondrocyte specific factors,  as  ovotransferrin, could 
participate in the activation of preosteoblastic cell differenti- 
ation program. With continuing development, differentiated 
mineralized  osteoblasts  start  producing  ovotransferrin in 
turn. Therefore, at this stage, an additional autocrine loop 
leading to the activation of more preosteoblastic cells could 
be envisaged. In the embryo limbs, at the time the initial car- 
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of ovotransferrin receptor in 
the developing chick embryo 
tibia. Sections of 7-d (a), 9-d 
(b-c),  and  13-d (d-f)  tibiae 
were stained with an antiserum 
directed  against the  oviduct 
ovotransferrin  receptor. (b and 
d) Epiphyseal region of tibia. 
(c, e-f) Mid-diaphysis region. 
Oviduct ovotransferrin recep- 
tors are present in the cartilag- 
inous rudiment at 7 days and 
in all cartilages at other devel- 
opmental stages, but they are 
highly  enriched  only in  the 
13-d tibia at the osteoblast side 
of the chondro-bone junction. 
At 13 day also the primordia 
of the menisci, which is nega- 
tive  for  ovotransferrin  (see 
Fig.  1),  is  stained  by  the 
anti-oviduct-ovotransferrin  re- 
ceptor antibodies. HC, hyper- 
trophic chondrocyte; OB, os- 
teoblast;  SC,  stacked  cell 
layer. Bars: (A) 100/am; (B-E) 
200/am; (F) 50 lam. 
tilage and bone are formed, blood vessels are not present and 
the bone rudiment is not vascularized, a local production of 
ovotransferrin appears to be the only way to make this factor 
available to the differentiating cartilage and bone cells. 
Interestingly high levels of oviduct receptor were observed 
at  13 day also in the primordia of the menisci.  At this de- 
velopmental stage, these cells do not express ovotransferrin, 
but, on the contrary, ovotransferrin is detectable in the re- 
gion of the prearticular cartilage. This finding suggests the 
existence of paracrine mechanisms also during bone joint 
morphogenesis. 
Ovotransferrin function during the cartilage and bone for- 
mation  can  be  only hypothesized.  Transferrins reversibly 
bind iron. Transferrin receptors are expressed at particularly 
high levels in the erythroid cell lineage between the early and 
intermediate normoblast stages when the iron requirement 
is at the highest level; subsequently their number decreases 
and finally disappears in the mature red blood cells (New- 
man et al., 1982; Horton, 1983; Chan and Gerhardt, 1992). 
In addition or in association with their role as iron trans- 
porters, transferrins play a role as mitogenic factors. Trans- 
ferrin receptors are in fact associated with actively prolifer- 
ating ceils, both in vertebrates and invertebrates (Huebers 
and Finch, 1987). A neuro- and myotrophic activity of trans- 
ferrin has  also been proposed.  Transferrin is essential for 
myotube development in  tissue  culture  (Li  et  al.,  1982; 
Beach et al.,  1985) and is required for the maintenance of 
the differentiated state of the striated muscle by the nerve 
(Stamatos and Fine, 1986). A similar situation may occur in 
brain where the transferrin produced by oligodendrocytes 
and other cells probably plays atrophic role on developing 
neurons and astrocytes (Aizenman et al.,  1986).  Finally a 
role for transferrin and its receptor in embryonic morpho- 
genesis has been shown by Ekblom et al.  (1983) in mouse 
organ cultures of developing kidneys and teeth (Partanen et 
al.,  1984). Transferrin is necessary to cell proliferation and 
cell differentiation. According to our results ovotransferrin 
is expressed in regions of the embryonic cartilage and bone 
characterized both by cell proliferation and cell differentia- 
tion. It should be recalled that often cell differentiation is 
preceded by a burst of cell proliferation. Therefore, in de- 
veloping bone ovotransferrin might play a role in the control 
of both differentiation and proliferation of chondrocytes and 
osteoblasts. 
Ovotransferrin is particularly expressed in regions where 
tissue morphogenesis occurs. Retinoic acid is a well known 
morphogenetic  factor.  Retinoic  acid  responsive  elements 
have been  identified  on  transferrin  promoters  (Ham  and 
Gentili et al. Ovotransferrin Expression in the Developing Tibia  587 Griswald,  1986).  We have shown an inductive effect of reti- 
noic acid on ovotransferrin expression in cultured chondro- 
cytes (Descalzi Cancedda et al.,  1992; Gentili et al.,  1993). 
Levels of transferrin  and transferrin  mRNA  are responsive 
to added retinoids also in cultured Sertoli cells (Hugly and 
Griswold,  1987). It is interesting to note that the Ch21, a pro- 
tein belonging to the lipocalin family (extracellular transport 
proteins for small hydrophobic ligands, such as steroids, reti- 
noids,  and  other  small hydrophobic  regulatory  molecules) 
(Descalzi Cancedda et al.,  1990),  is produced by chondro- 
cytes and is localized in the same regions where ovotransfer- 
rin  is observed  (Manduca  et al.,  1989).  We would like to 
suggest that ovotransferrin is a member of a  whole group of 
proteins  coordinately expressed in areas of chondrogenesis 
and osteogenesis. 
The finding that at late stage of development the presence 
of ascorbic acid,  i.e., the assembly of an extracellular ma- 
trix,  is an absolute requirement  for the expression of ovo- 
transferrin by chondrocytes is per se an interesting observa- 
tion  worth  additional  comments.  Ovotransferrin  is not the 
only example where the interaction of the chondrocyte with 
an organized extracellular matrix is necessary for gene acti- 
vation.  A  control over gene expression depending upon the 
chondrocyte-extracellular matrix interaction has been shown 
also in the case of the RIHB (Retinoic Induced Heparin Bind- 
ing factor (Castagnola,  P.,  S.  Tavella, M.  Gennari,  R.  van 
der  Werken,  P.  Raffo,  D.  Ravlais,  M.  Vigny,  and  R. 
Cancedda, manuscript submitted for publication) and in the 
case  of  a  newly  described  angiogenic  activity  (Descalzi 
Cancedda,  E,  A.  Melchiori,  R.  Benelli,  C.  Gentili,  L. 
Masiello, G. Campanile, R. Cancedda, and A. Albini, manu- 
script submitted  for publication).  It therefore appears  that, 
in order to fully express their differentiated phenotype, chon- 
drocytes need to interact with an organized extracellular ma- 
trix that  they deposit by themselves. 
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